Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The compound 4c showed strong potential as an anticancer agent.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Birth control pills can help reduce mild to moderate acne in women.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Certain drugs that block specific enzymes can help treat prostate diseases.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

N-oxides are important in medicine for improving drug properties and targeting.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

A PEG-400/oleic acid mixture best improves drug delivery monitoring through hair follicles.

Dutasteride may help reduce brain inflammation and improve cognition.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

A blood pressure drug, diltiazem, may also help treat influenza.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Potential new drugs for treating PCOS were identified.